Journey Medical Corporation
DERM
$7.48
$0.030.40%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 20.68% | 15.89% | 11.07% | 0.04% | -5.18% |
| Total Other Revenue | 33.00% | -34.10% | -38.10% | -- | -94.81% |
| Total Revenue | 20.89% | 15.00% | 10.20% | 2.82% | -27.40% |
| Cost of Revenue | 24.77% | 13.65% | 0.21% | 9.30% | -7.48% |
| Gross Profit | 18.95% | 15.73% | 16.11% | -0.22% | -34.50% |
| SG&A Expenses | -2.26% | 3.67% | 10.36% | 11.45% | 17.95% |
| Depreciation & Amortization | 7.65% | 17.56% | 24.39% | -32.78% | -27.27% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.54% | 12.46% | 0.31% | -14.37% | -16.28% |
| Operating Income | 56.15% | 8.26% | 40.25% | 69.50% | -422.98% |
| Income Before Tax | 29.34% | -15.60% | 22.18% | 53.09% | -909.87% |
| Income Tax Expenses | -87.60% | -1.64% | -1.64% | -3.97% | -45.25% |
| Earnings from Continuing Operations | 30.14% | -15.48% | 22.09% | 52.75% | -1,136.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 30.14% | -15.48% | 22.09% | 52.75% | -1,136.54% |
| EBIT | 56.15% | 8.26% | 40.25% | 69.50% | -422.98% |
| EBITDA | 141.42% | 37.55% | 61.83% | 91.05% | -154.55% |
| EPS Basic | 40.27% | 2.47% | 35.02% | 60.71% | -486.55% |
| Normalized Basic EPS | 47.13% | 14.44% | 39.58% | 63.18% | -489.60% |
| EPS Diluted | 40.27% | 2.47% | 35.02% | 60.89% | -2,371.97% |
| Normalized Diluted EPS | 47.13% | 14.44% | 39.58% | 63.18% | -24,763.64% |
| Average Basic Shares Outstanding | 21.78% | 21.56% | 20.06% | 16.70% | 14.17% |
| Average Diluted Shares Outstanding | 21.78% | 21.56% | 20.06% | 16.70% | 10.41% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |